Movement Alert|Albemarle Rises 5.16% in Regular Trading, Q2 Earnings Beat Expectations as Institutions Remain Bullish on Lithium Demand

Market Focus
Aug 14

On August 14, Albemarle rose 5.16% in regular trading, trading at $137.03/share, with turnover of $87.75 million. The stock continues to benefit from strong Q2 results and institutional optimism on lithium demand fundamentals.

Albemarle reported Q2 net sales of $1.74 billion, up 31% year-over-year and approximately 8% above consensus estimates. Adjusted EPS came in at $3.75, a dramatic increase from $0.11 a year earlier and roughly 16% above the Street estimate of $3.24. The company raised its full-year specialties segment revenue guidance to $1.4-1.6 billion and lifted battery energy storage production expectations by 11%.

CEO Kent Masters highlighted that global lithium inventories remain at low levels, with weak supply failing to keep pace with growing EV and battery storage demand. The company raised the low end of its global lithium demand forecast by 100,000 metric tons through 2030. RBC Capital Markets noted Albemarle will likely benefit from low-cost assets, brownfield expansion opportunities, and significant demand growth for energy storage systems. The current analyst mean price target stands at approximately $177.67, suggesting meaningful upside from current levels.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10